0001209191-20-056934.txt : 20201104
0001209191-20-056934.hdr.sgml : 20201104
20201104171040
ACCESSION NUMBER: 0001209191-20-056934
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201102
FILED AS OF DATE: 20201104
DATE AS OF CHANGE: 20201104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHEN JIN-LONG
CENTRAL INDEX KEY: 0001642996
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38853
FILM NUMBER: 201287530
MAIL ADDRESS:
STREET 1: 630 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NGM BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001426332
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 333 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-243-5555
MAIL ADDRESS:
STREET 1: 333 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-02
0
0001426332
NGM BIOPHARMACEUTICALS INC
NGM
0001642996
CHEN JIN-LONG
333 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
Chief Scientific Officer
Common Stock
2020-11-02
4
S
0
25000
17.70
D
920005
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2020.
Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.355 to $17.79. The reporting person has provided to the issuer, and undertakes to provide to the staff of the Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Jin-Long Chen
2020-11-04